TT Electronics jumps as stronger second-half drives profit, cash gains

Revenue fell 7.6% to £481.4m in FY2025 while adjusted operating profit rose 2.2% to £37.2m and margin improved to 7.7%. Adjusted EPS dropped to 6.9p from 11.0p and the group reported a statutory operating loss of £28.2m after £65.4m of largely non‑cash charges, but free cash flow rose to £29.9m (cash conversion 150%), net debt fell to £50.3m and leverage improved to 1.1x. The company expects 2026 revenue and adjusted operating profit in line with consensus; brokers noted improved cash and leverage but said the turnaround—particularly in U.S. and Asia—remains a work in progress.

Analysis

TT’s trajectory should be framed as a capital-allocation and optionality story rather than a pure revenue-recovery trade. Reduced leverage and strong cash conversion materially compress the threshold for strategic outcomes — a modest improvement in order momentum or a single mid-market bid could re-rate equity multiples by 30-50% within 6-12 months given the lower balance-sheet risk and improved FCF profile.

The asymmetric risks are concentrated in demand and execution: continued softness in Asia or a reversal in North American operational progress would force further restructuring and could trigger additional non‑cash impairments, compressing headline earnings for at least 2-3 quarters. Conversely, stable aerospace & defence exposure provides a defensive earnings backbone and raises the floor for free-cash-flow, which limits downside versus higher-beta EMS peers.

Second-order supply-chain effects matter: customer transfer activity is simultaneously a short-term headwind and a long-term consolidation opportunity — winners will be EMS players that can absorb transferred volumes with minimal incremental capex, creating a two-tier outcome over 6-18 months. That bifurcation makes a dedicated event-driven / relative value approach preferable to a plain long-beta position on cyclical EMS demand.

Key Decisions for Investors

• Event-driven long TTG (LSE:TTG) — 6–12 month horizon, 2–3% portfolio weight. Entry: buy into any pullback toward the pre-earnings level or on weakness in European small-caps; target 40–50% total return vs stop at -20%. Rationale: low leverage raises M&A optionality and reduces downside; catalyst window 3–12 months (order momentum, potential strategic interest).
• Relative-value long Celestica (NYSE:CLS) — 6–12 months, 2% weight. Entry on a <5% weakness or buy 3–6 month call-backspread if volatility cheap; target 30% upside if share gains accelerate from customer transfer activity. Risk: semiconductor capital cycles and Asian demand weakness; hedge with short exposure to an Asian-focused EMS ETF or stock.
• Pair trade: short SMCI (NASDAQ:SMCI) vs long TTG — 3–6 month tactical rotation, dollar‑neutral sizing. Thesis: de-risk from frothy AI/hardware multiple while capturing re‑rating of cash-generative EMS; target 20–30% relative outperformance, stop if SMCI outperforms TTG by >25% in 30 days. SMCI tail-risk is continued multiple expansion; keep position small.
• Protective options: buy a 6–9 month put (or put spread) on TTG sized to cap downside to ~10–12% of position notional while financing via a small call-sell if carry is attractive. Use this when volatility is < historical post-earnings level to limit downside from surprise order deterioration while retaining upside to an M&A rerate.